Avacta Group (AVCT)

 

Latest News

Private Shareholder Update Event

RNS Number: 9378T Avacta Group PLC 19 October 2017 19 October 2017 Avacta Group plc ("Avacta" or "the Company") Private Shareholder Update Event Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, will be hosting a Private Shareholder event on Wednesday, 15 November 2017 at 2.00 pm until 4.00 pm at finnCap's offices...

Hardman Res.: R&D accelerated to advance assets

RNS Number: 6904T Avacta Group PLC 16 October 2017 Hardman Res.: R&D accelerated to advance assets R&D accelerated to advance assets - Avacta is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology which domin...

Avacta to present at Shares Spotlight Evening

Avacta Group chief executive Alastair Smith will be presenting at the Shares Spotlight Evening on 19 Oct at the Novotel Ho...

Avacta to Present at Shares Spotlight Evening

RNS Number: 3574T Avacta Group PLC 12 October 2017 12 October 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta to Present at Shares Spotlight Evening in London Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, is pleased to announce that its Chief Executive Officer, Alastair Smith, wil...

All News

DateHeadlineSource
19-10-17Private Shareholder Update EventRNS
16-10-17Hardman Res.: R&D accelerated to advance assetsRNS
12-10-17Avacta to present at Shares Spotlight EveningStockMarketWire
12-10-17Avacta to Present at Shares Spotlight EveningRNS
10-10-17Avacta to present at the Shares Spotlight Evening in London on 19 October 2017StockMarketWire
10-10-17Avacta CTO to present at US conference StockMarketWire
10-10-17Avacta to Present at Major US ConferenceRNS
09-10-17Director Dealing and Issue of EquityRNS
05-10-17Avacta research collaboration with FIT BiotechStockMarketWire
05-10-17Research collaboration with FIT Biotech OyRNS
04-10-17Avacta revenues rise but losses widen StockMarketWire
04-10-17Preliminary ResultsRNS
02-10-17Avacta establishes US business development teamStockMarketWire
02-10-17Avacta establishes US business development teamRNS
07-09-17Notice of ResultsRNS
21-08-17Director Deals - Avacta Group PLC (AVCT)StockMarketWire
21-08-17Director/PDMR ShareholdingRNS
07-08-17Avacta revenues rise StockMarketWire
07-08-17Trading UpdateRNS
31-07-17Issue of EquityRNS
28-07-17Director/PDMR ShareholdingRNS
05-07-17Director Dealing and Issue of EquityRNS
04-07-17Manchester ShareSoc Growth Company SeminarRNS
05-06-17ShareSoc Growth Company SeminarRNS
01-06-17Issue of EquityRNS
22-05-172 Biotech's Licence Affimers for Research UseRNS
10-05-17Avacta to be granted patent in China StockMarketWire
08-05-17Moderna releases Phase I trial data for mRNA technologyStockMarketWire
08-05-17Hardman Research: De-risking Moderna's partnershipRNS
05-05-17Avacta CEO to present at Hardman forum StockMarketWire
05-05-17Presenting at the Hardman Private Investor ForumRNS
02-05-17Avacta to Present at BioTrinity 2017RNS
24-04-17Avacta agrees exclusive deal with global diagnostics firm StockMarketWire
24-04-17Diagnostics firm take rights to several AffimersRNS
19-04-17Avacta to present at Shares Spotlight EveningStockMarketWire
19-04-17Avacta to Present at the Shares Spotlight EveningRNS
12-04-17Hardman Research: Another important box tickedRNS
06-04-17Holding(s) in CompanyRNS
06-04-17Holding(s) in CompanyRNS
06-04-17Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory